Literature DB >> 32171062

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Lei Fang1, George Karakiulakis2, Michael Roth3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32171062      PMCID: PMC7118626          DOI: 10.1016/S2213-2600(20)30116-8

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  5 in total

Review 1.  The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.

Authors:  Xiao C Li; Jianfeng Zhang; Jia L Zhuo
Journal:  Pharmacol Res       Date:  2017-06-12       Impact factor: 7.658

2.  Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.

Authors:  Jin-Jin Zhang; Xiang Dong; Yi-Yuan Cao; Ya-Dong Yuan; Yi-Bin Yang; You-Qin Yan; Cezmi A Akdis; Ya-Dong Gao
Journal:  Allergy       Date:  2020-02-27       Impact factor: 13.146

3.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

4.  Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.

Authors:  Yushun Wan; Jian Shang; Rachel Graham; Ralph S Baric; Fang Li
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

5.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

  5 in total
  986 in total

Review 1.  Dissecting the interaction between COVID-19 and diabetes mellitus.

Authors:  Ying Jie Chee; Seng Kiong Tan; Ester Yeoh
Journal:  J Diabetes Investig       Date:  2020-08-05       Impact factor: 4.232

2.  Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China.

Authors:  Juyi Li; Xiufang Wang; Jian Chen; Hongmei Zhang; Aiping Deng
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

3.  Cardiac involvement in critically ill and mechanically ventilated patients with COVID-19 - a prospective, observational echocardiographic study.

Authors:  Nina Norden; Erik O Lundin; Eva Hagberg; Sinsia A Gao; Mathias Hård Af Segerstad; Bengt Nellgård; Keti Dalla
Journal:  Am J Cardiovasc Dis       Date:  2021-04-15

Review 4.  Molecular Aspects of Co-morbidities in COVID-19 Infection.

Authors:  Farzaneh Pouya; Zeynab Imani Saber; Mohammad Amin Kerachian
Journal:  Arch Bone Jt Surg       Date:  2020-04

5.  Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.

Authors:  Jan Wysocki; Enrique Lores; Minghao Ye; Maria Jose Soler; Daniel Batlle
Journal:  J Am Soc Nephrol       Date:  2020-07-15       Impact factor: 10.121

Review 6.  ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective.

Authors:  Andrew M South; Tammy M Brady; Joseph T Flynn
Journal:  Hypertension       Date:  2020-05-05       Impact factor: 10.190

Review 7.  COVID-19 Treatment at a Glance.

Authors:  Hüseyin Arıkan; Dilek Karadoğan; Fatma Tokgöz Akyıl; Aycan Yüksel; Zehra Nur Töreyin; Canan Gündüz Gürkan; Feride Marim; Tuğba Şişmanlar Eyüboğlu; Nagehan Emiralioğlu; Tuğba Ramaslı Gürsoy; İrem Şerifoğlu; Abdulsamet Sandal; Aslı Öncel; Berrin Er; Neslihan Köse; Dorina Esendağlı; Mina Hızal; Aslıhan Banu Er; Fatma Esra Günaydın; İlknur Kaya; Hilal Özakıncı; Ümran Özden Sertçelik; Hatice Çelik Tuğlu; Nilüfer Aylin Acet Özürk; Özlem Ataoğlu; Ahu Cerit Çakır; Hüseyin Toptay; Merve Erçelik; Elif Develi; Selman Çelik; Fatma Gülsüm Karakaş; Halime Yıldırım; Damla Karadeniz Güven; Nazlı Çetin; Sümeyye Nur Aslan Küçükyurt; Mehmet Fatih Elverişli; Pinar Yıldız Gülhan; Metin Akgün
Journal:  Turk Thorac J       Date:  2020-11-01

Review 8.  Review of Pharmacotherapy Trialed for Management of the Coronavirus Disease-19.

Authors:  Kimberly Hall; Fuhbe Mfone; Michael Shallcross; Vikas Pathak
Journal:  Eurasian J Med       Date:  2021-06

9.  Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.

Authors:  Henry Sackin
Journal:  Med Hypotheses       Date:  2021-05-12       Impact factor: 1.538

10.  Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?

Authors:  Concepción Peiró; Salvador Moncada
Journal:  Circulation       Date:  2020-04-03       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.